Shares of Avantor, Inc. (NYSE:AVTR – Get Free Report) have received an average rating of “Moderate Buy” from the sixteen analysts that are covering the stock, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The average 12 month price target among analysts that have updated their coverage on the stock in the last year is $27.40.
A number of equities research analysts have issued reports on the stock. Stifel Nicolaus increased their price objective on shares of Avantor from $27.00 to $28.00 and gave the stock a “buy” rating in a research note on Monday, July 29th. Barclays boosted their price objective on shares of Avantor from $25.00 to $28.00 and gave the company an “overweight” rating in a research report on Monday, July 29th. TD Cowen raised their target price on Avantor from $28.00 to $31.00 and gave the company a “buy” rating in a report on Monday, July 29th. Wells Fargo & Company started coverage on Avantor in a research note on Tuesday, August 27th. They issued an “overweight” rating and a $30.00 price target on the stock. Finally, Royal Bank of Canada restated an “outperform” rating and set a $31.00 price objective on shares of Avantor in a research report on Monday, July 29th.
View Our Latest Stock Report on Avantor
Insider Activity
Institutional Investors Weigh In On Avantor
Institutional investors have recently made changes to their positions in the stock. Boston Partners raised its position in shares of Avantor by 2.2% during the first quarter. Boston Partners now owns 28,561,802 shares of the company’s stock worth $729,298,000 after acquiring an additional 624,369 shares during the last quarter. Canada Pension Plan Investment Board raised its holdings in Avantor by 6.8% during the 2nd quarter. Canada Pension Plan Investment Board now owns 22,927,325 shares of the company’s stock worth $486,059,000 after purchasing an additional 1,463,695 shares during the last quarter. Artemis Investment Management LLP lifted its position in shares of Avantor by 14.9% in the 1st quarter. Artemis Investment Management LLP now owns 9,120,083 shares of the company’s stock worth $233,109,000 after purchasing an additional 1,180,937 shares during the period. 1832 Asset Management L.P. boosted its stake in shares of Avantor by 1,634.9% in the 2nd quarter. 1832 Asset Management L.P. now owns 8,530,118 shares of the company’s stock valued at $180,839,000 after purchasing an additional 8,038,451 shares during the last quarter. Finally, Bessemer Group Inc. increased its position in shares of Avantor by 4.4% during the first quarter. Bessemer Group Inc. now owns 7,099,848 shares of the company’s stock worth $181,544,000 after buying an additional 297,534 shares during the period. Institutional investors own 95.08% of the company’s stock.
Avantor Stock Down 1.5 %
NYSE AVTR opened at $26.58 on Tuesday. The company has a market cap of $18.05 billion, a price-to-earnings ratio of 68.15, a PEG ratio of 2.75 and a beta of 1.32. Avantor has a 1-year low of $16.63 and a 1-year high of $28.00. The company has a current ratio of 1.59, a quick ratio of 1.05 and a debt-to-equity ratio of 0.89. The company has a 50 day moving average of $25.16 and a 200-day moving average of $24.36.
Avantor (NYSE:AVTR – Get Free Report) last released its earnings results on Friday, July 26th. The company reported $0.25 earnings per share for the quarter, beating analysts’ consensus estimates of $0.23 by $0.02. Avantor had a return on equity of 12.40% and a net margin of 5.28%. The firm had revenue of $1.70 billion during the quarter, compared to the consensus estimate of $1.70 billion. On average, equities research analysts expect that Avantor will post 1.01 earnings per share for the current fiscal year.
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Stories
- Five stocks we like better than Avantor
- Energy and Oil Stocks Explained
- The Average 401k Balance by Age Explained
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- What Are Dividend Champions? How to Invest in the Champions
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.